Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis. | Front Mol Biosci | 2023 | 37152902 | PubTator, text mining | PubMed |
| Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma. | Int J Biol Sci | 2023 | 37151879 | PubTator, text mining | PubMed |
| Pregnancy in MuSK-positive myasthenia gravis: A single-center case series. | Muscle Nerve | 2023 | 37150596 | PubTator, text mining | PubMed |
| Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study. | Front Neurol | 2023 | 37139075 | PubTator, text mining | PubMed |
| Miller Fisher Syndrome With Positive Anti-GQ1b/GQ1d Antibodies Associated With COVID-19 Infection: A Case Report. | Cureus | 2023 | 37128531 | PubTator, text mining | PubMed |
| Myasthenic crisis. | Muscle Nerve | 2023 | 37114503 | PubTator, text mining | PubMed |
| Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis. | Life (Basel) | 2023 | 37109594 | PubTator, text mining | PubMed |
| Myasthenia gravis, respiratory function, and respiratory tract disease. | J Neurol | 2023 | 37101094 | PubTator, text mining | PubMed |
| The unique properties of IgG4 and its roles in health and disease. | Nat Rev Immunol | 2023 | 37095254 | PubTator, text mining | PubMed |
| Balancing WNT signalling in early forebrain development: The role of LRP4 as a modulator of LRP6 function. | Front Cell Dev Biol | 2023 | 37091972 | PubTator, text mining | PubMed |
| Case Report: Congenital Myasthenic Syndrome Presenting with Bilateral Vocal Cord Paralysis Caused by De-Novel Compound Heterozygous MUSK Mutation. | Pharmgenomics Pers Med | 2023 | 37091828 | PubTator, text mining | PubMed |
| New diagnosis of myasthenia gravis in the third trimester - A case report. | Case Rep Womens Health | 2023 | 37090685 | PubTator, text mining | PubMed |
| How to improve the sensitivity and specificity of cell-based assays in detecting autoantibodies in neuroimmune diseases. | Ann Transl Med | 2023 | 37090047 | PubTator, text mining | PubMed |
| A narrative review of identifying the culprit antibody in neuroimmune diseases: concept and clinical significance. | Ann Transl Med | 2023 | 37090046 | PubTator, text mining | PubMed |
| Optimal validation of accuracy in antibody assays and reasonable definition of antibody positive/negative subgroups in neuroimmune diseases: a narrative review. | Ann Transl Med | 2023 | 37090045 | PubTator, text mining | PubMed |
| Serological diagnosis of myasthenia gravis and its clinical significance. | Ann Transl Med | 2023 | 37090043 | PubTator, text mining | PubMed |
| Oxymetazoline Hydrochloride Eye-Drops as Treatment for Myasthenia Gravis-Related Ptosis: A Description of Two Cases. | Cureus | 2023 | 37082493 | PubTator, text mining | PubMed |
| Robotic thymectomy: a review of techniques and results. | Kardiochir Torakochirurgia Pol | 2023 | 37077455 | PubTator, text mining | PubMed |
| Principles of Therapeutic Apheresis in Neurological Disease. | Transfus Med Hemother | 2023 | 37066058 | PubTator, text mining | PubMed |
| Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study. | Lancet Neurol | 2023 | 37059507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=27